How Aptamer Technology Transforms Anticoagulation Strategies
Thrombin Antibodies: How Aptamer Technology Transforms Anticoagulation Strategies
Powered by ANT BIO PTE. LTD.
Concept
Thrombin is a 37 kDa serine protease composed of 308 amino acids, derived from the 582‑amino‑acid precursor prothrombin. Upon proteolytic activation, it forms a disulfide‑linked two‑chain structure: a 36‑residue A chain for structural stability and a 259‑residue B chain containing the catalytic active site, exosite I (fibrinogen‑binding), and exosite II (heparin‑binding). This central coagulation enzyme drives fibrin clot formation and platelet activation, making it a pivotal target for anticoagulation research and therapy.
Research Frontier
Aptamer technology has emerged as a transformative molecular recognition platform in precision anticoagulation. Since the first thrombin aptamer HD1 was identified in 1992, researchers have developed high‑affinity single‑stranded DNA/RNA aptamers via SELEX that selectively target exosite I or exosite II with nanomolar affinity. Unlike conventional antibodies, aptamers form stable G‑quadruplex structures, exhibit superior thermal and pH stability, enable precise chemical modification, and show minimal immunogenicity. Dual‑aptamer strategies targeting both exosites now achieve synergistic, reversible thrombin inhibition, overcoming limitations of heparin and antibody‑based approaches.
Research Significance
Dysregulated thrombin activity underlies life‑threatening conditions including venous thromboembolism, myocardial infarction, stroke, and disseminated intravascular coagulation. Traditional anticoagulants often lack specificity and carry bleeding risks. Aptamer‑directed thrombin inhibition enables site‑specific, controllable, and reversible anticoagulation with improved safety and pharmacokinetic tunability. This approach advances personalized precision medicine for thrombotic disorders and supports mechanistic studies of coagulation, inflammation, and vascular biology.
Related Mechanisms and Research Applications
Molecular Mechanism
Thrombin’s B chain contains three functional domains:
- Catalytic active site for proteolytic cleavage
- Exosite I: fibrinogen and receptor recognition
- Exosite II: heparin binding via six lysine residues
Aptamers such as HD1 (G‑quadruplex) block exosite I to prevent fibrinogen recognition, while HD22 targets exosite II to disrupt heparin cofactor interactions. Both achieve rapid, reversible inhibition with high spatial precision.
Key Research Applications
- Mechanistic studies of coagulation cascade regulation
- Development of controllable anticoagulant therapeutics
- Thrombosis model validation and drug screening
- Detection and quantification of thrombin in biological samples
- Investigation of thrombin‑related inflammatory and tumor microenvironment signaling
ANTBIO Product Enablement
ANT BIO PTE. LTD. provides high‑performance reagents to accelerate thrombin and anticoagulation research:
- Antithrombin III Recombinant Rabbit mAb (SDT‑294‑303, Cat. No. S0B3117)
Specifically recognizes antithrombin III, the primary endogenous thrombin inhibitor. Validated for IHC and WB, this recombinant monoclonal antibody delivers high specificity, low background, and exceptional batch consistency. It enables precise localization and quantification of ATIII in FFPE tissues, supporting studies of hemostasis, liver function, and hereditary ATIII deficiency.
- Supporting products: Thrombin‑targeted antibodies, coagulation‑related ELISA kits, and general reagents optimized for reproducible results.
Brand Mission
ANT BIO PTE. LTD. is committed to advancing life science discovery by delivering reliable, high‑quality reagents tailored to coagulation, cardiovascular, and immunology research. Our integrated portfolio of antibodies, proteins, ELISA kits, and general reagents empowers scientists worldwide to explore disease mechanisms, validate therapeutic targets, and translate basic insights into clinical progress.
Related Product List
- Antithrombin III Recombinant Rabbit mAb (SDT‑294‑303)
Cat. No.: S0B3117
Applications: IHC, WB
Host: Rabbit
Reactivity: Human
Features: High specificity, stable staining, excellent consistency
- Human Antithrombin III ELISA Kit
Cat. No.: abs551xxx
Application: Quantitative measurement in serum, plasma, tissue homogenates
Method: Sandwich ELISA
Range: 6.25–400 ng/mL
- Thrombin Monoclonal Antibody
Cat. No.: S0Bxxxx
Applications: WB, ELISA, IHC
Host: Mouse
Reactivity: Human, Mouse
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
